Table 3.
Author | Year | Instrumented Intervention Patients | Instrumented Control Patients | Deep SSI rate in Instrumented Intervention Patients | Deep SSI Rate in Instrumented Control Patients |
---|---|---|---|---|---|
Intrawound antibiotics | |||||
Garg et al | 2018 | 228 | 310 | 3.1% (7/228) | 1.9% (6/310) |
Thompson et al | 2018 | 104 | 87 | 4.8% (5/104) | 13.8% (12/87) |
Haller et al | 2017 | 169 | 1028 | 1.8% (3/169) | 3.5% (36/1028) |
Hey et al | 2017 | 117 | 272 | 0.9% (1/117) | 3.7% (10/272) |
Liu et al | 2015 | 180 | 154 | 2.8% (5/180) | 7.1% (11/154) |
Hill et al | 2014 | 128 | 81 | 0% (0/128) | 7.4% (6/81) |
Emohare et al | 2014 | 78 | 122 | 0% (0/78) | 3.3% (4/122) |
Theologis et al | 2014 | 151 | 64 | 2.7% (4/151) | 10.9% (7/64) |
Tubaki et al | 2013 | 302 | 304 | 2.0% (6/302) | 1.6% (5/304) |
Strom et al (1)34 | 2013 | 79 | 92 | 2.5% (2/79) | 10.9% (10/92) |
Strom et al (2)35 | 2013 | 88 | 77 | 0% (0/88) | 11.7% (9/77) |
Pahys et al | 2013 | 172 | 405 | 0% (0/172) | 1.7% (7/405) |
Caroom et al | 2013 | 40 | 72 | 0% (0/40) | 15.3% (11/72) |
Heller et al | 2013 | 342 | 341 | 0% (0/342) | 3.5% (12/341) |
Kim et al | 2013 | 34 | 40 | 0% (0/34) | 7.5% (3/40) |
Sweet et al | 2011 | 911 | 821 | 0.2% (2/911) | 2.6% (21/821) |
Intrawound antiseptics | |||||
De Luna et al | 2017 | 25 | 25 | 0% (0/25) | 12.0% (3/25) |
Herwijnen et al | 2016 | 71 | 15 | 4.2% (3/71) | 20.0% (3/15) |
Ulivieri et al | 2011 | 100 | 95 | 0% (0/100) | 7.4% (7/95) |
Chang et al | 2006 | 120 | 124 | 0% (0/120) | 4.8% (6/124) |
Abbreviation: SSI, surgical site infection.